Pulmonary embolism and aseptic meningitis complicating IVIG for common variable immunodeficiency syndrome
Daniel Butz, Arun Adlakha

TL;DR
A patient with an immune disorder experienced serious side effects from a treatment, showing the need for careful monitoring and adjustments.
Contribution
The paper introduces a multifaceted management approach to handle complications from IVIG in immunodeficiency patients.
Findings
Patients with common variable immunodeficiency can experience severe adverse events from IVIG.
Modifying the product, infusion rate, and premedication can help manage these complications effectively.
Abstract
This case highlights the importance of vigilance for both thrombotic and inflammatory adverse events in patients with common variable immunodeficiency who are receiving intravenous immunoglobulin. It demonstrates that a multifaceted approach, including altering the product, infusion rate, and premedication, can effectively manage these complex complications.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmunodeficiency and Autoimmune Disorders · Platelet Disorders and Treatments · interferon and immune responses
